ClinicalTrials.gg
RecruitingNCT06898073Updated Jun 10, 2025

Dual-task Training During Curved Walking in Stroke Patients

An interventional study of cognitive dual-task group and Single-task group in Stroke Rehabilitation, sponsored by Fooyin University. Recruiting at 1 site in Taiwan. Open to participants aged 40 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-06-10.

Sponsored by Fooyin University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jul 2026, 3 months ago, but the record still lists the study as recruiting.
  • Started Mar 2025; still recruiting 1 year 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
40 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 394 studies in Stroke with a site in Taiwan — 73 open to participants now, 82 under way, 4 of them phase 3. Stroke · Taiwan.

Planned enrollment
145th of 337
60 · median 54
Started
2025
with 21 others
No phase
261 of 394
63 open now
Primary completion
2026-07
later than 32 of 81 live
Registered
360th of 394
by date

Among the 394 studies in Stroke with a site in Taiwan, this one is the 145th largest by planned enrollment of the 337 interventional ones that give a count, is one of 22 that started in 2025, is one of 261 with no phase, reaches primary completion later than 32 of the 81 other live ones, and was the 360th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

73 of the 394 studies in Stroke with a site in Taiwan are open now. Recruiting first, the newest first:

67 more — sign in →

All 73 open studies →

A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 40 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 394 studies in Stroke with a site in Taiwan, or all of them as a file.
02

Study summary

The purpose of this study is to explore the effects of curved walking training under dual-task conditions on the cognitive function and walking ability of stroke patients.

03

Conditions studied

  • Stroke Rehabilitation

Browse trials for

04

Who can participate

Ages eligible
40 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. First-time unilateral stroke
  2. Age between 40 and 80 years
  3. Able to walk 10 meters continuously with or without the use of assistive devices
  4. Capable of following instructions and performing simple arithmetic
  5. Brunnstrom stage 3 or higher

Exclusion criteria

Exclusion Criteria:

  1. Other neurological disease or unstable medical conditions
  2. Visual field defect
  3. (MMSE) \<24 points
  4. Pusher syndrome
  5. Half-sided neglect
  6. Expressive aphasia
  7. Poorly controlled hypertension or cardiovascular disease
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Cognitive tasks as the second task in addition to walking

    Behavioral: cognitive dual-task group

  • Other
    walking without performing a second task during the walking training

    Behavioral: Single-task group

Interventions

  • Behavioralcognitive dual-task group

    Cognitive tasks as the second task in addition to walking

  • BehavioralSingle-task group

    walking without performing a second task during the walking training

06

What researchers measure

Primary outcomes

  1. Mini-Mental State Examination

    Mini-Mental State Examination (MMSE) includes items such as orientation, attention, memory, language, verbal comprehension, executive function, and construction ability. The maximum score is 30 points. A higher score indicates better cognitive function. One point is given for each correct answer. A total score below 24 suggests mild cognitive impairment, while a score below 16 indicates severe cognitive impairment.

    Time frame: From baseline to the end of treatment at 3 weeks

  2. Trail Making Test

    The test consists of two parts, A and B. In part A, the participant is asked to connect a series of numbers in sequential order as quickly as possible. Part B includes both numbers and colors, where the participant must alternate between connecting the numbers and colors in order. The test records the time taken to complete the sequence and the number of errors made for scoring. If part B is not completed within 5 minutes, the test is stopped, and the highest score of 300 seconds is recorded. A lower score indicates faster completion time, suggesting better function.

    Time frame: From baseline to the end of treatment at 3 weeks

  3. Walking ability with different attention loads while turning - time

    The participant will be asked to walk 10 meters in a continuous curved path, without or with dual tasks. The time (seconds) taken to turn will be recorded using a stopwatch.

    Time frame: From baseline to the end of treatment at 3 weeks

  4. Walking ability with different attention loads while turning - numbers of steps

    The participant will be asked to walk 10 meters in a continuous curved path, without or with dual tasks. The numbers of steps taken to turn will be recorded using a counter.

    Time frame: From baseline to the end of treatment at 3 weeks

  5. Walking ability with different attention loads while turning - gait speed

    The participant will be asked to walk 10 meters in a continuous curved path, without or with dual tasks. Gait speed (m/s) will be recorded using the commercially available portable gait analysis system (Gait Up).

    Time frame: From baseline to the end of treatment at 3 weeks

  6. Walking ability with different attention loads while turning - step length

    The participant will be asked to walk 10 meters in a continuous curved path, without or with dual tasks. Step length (cm) during gait will be recorded and analyzed using the commercially available portable gait analysis system (Gait Up).

    Time frame: From baseline to the end of treatment at 3 weeks

  7. Walking ability with different attention loads while turning - step time

    The participant will be asked to walk 10 meters in a continuous curved path, without or with dual tasks. Step time (seconds) will be recorded and analyzed using the commercially available portable gait analysis system (Gait Up).

    Time frame: From baseline to the end of treatment at 3 weeks

  8. Walking ability with different attention loads while straight-line walking - time

    The participant will be asked to walk 10 meters in a straight-line path, without or with dual tasks. The time taken to turn will be recorded using a stopwatch.

    Time frame: From baseline to the end of treatment at 3 weeks

  9. Walking ability with different attention loads while straight-line walking - numbers of steps

    The participant will be asked to walk 10 meters in a straight-line path, without or with dual tasks. The numbers of steps taken to turn will be recorded using a counter.

    Time frame: From baseline to the end of treatment at 3 weeks

  10. Walking ability with different attention loads while straight-line walking - gait speed

    The participant will be asked to walk 10 meters in a straight-line path, without or with dual tasks. Gait speed will be recorded using the commercially available portable gait analysis system (Gait Up).

    Time frame: From baseline to the end of treatment at 3 weeks

  11. Walking ability with different attention loads while straight-line walking - step length

    The participant will be asked to walk 10 meters in a straight-line path, without or with dual tasks. Step length (cm) will be recorded using the commercially available portable gait analysis system (Gait Up).

    Time frame: From baseline to the end of treatment at 3 weeks

  12. Walking ability with different attention loads while straight-line walking - step time

    The participant will be asked to walk 10 meters in a straight-line path, without or with dual tasks. Step time (second) will be recorded using the commercially available portable gait analysis system (Gait Up).

    Time frame: From baseline to the end of treatment at 3 weeks

  13. Timed up and go test

    This test requires a 3-meter distance to be marked on the floor, with a chair placed at one end. The time which the participant stands up, walks forward to the 3-meter mark, turns around, walks back to the chair, and sits down again will be calculated and recorded.

    Time frame: From baseline to the end of treatment at 3 weeks

  14. Time taken to complete the Figure-of-Eight Walk test

    The figure-eight walking test path includes both straight and turning paths. The participant will first be asked to stand between two traffic cones, spaced 5 feet apart. They will then be instructed to walk forward, turn around the first cone in their preferred direction, return to the starting point, and then turn around the second cone in the opposite direction before returning to the center. The time taken to complete the figure-eight walking test will be recorded.

    Time frame: From baseline to the end of treatment at 3 weeks

  15. Numbers of steps to complete the Figure-of-Eight Walk test

    The figure-eight walking test path includes both straight and turning paths. The participant will first be asked to stand between two traffic cones, spaced 5 feet apart. They will then be instructed to walk forward, turn around the first cone in their preferred direction, return to the starting point, and then turn around the second cone in the opposite direction before returning to the center. Numbers of steps to complete the Figure-of-Eight Walk test will be recorded.

    Time frame: From baseline to the end of treatment at 3 weeks

Secondary outcomes

  1. Berg Balance Scale

    This scale includes 14 test items. The scoring for each item ranges from 0 to 4. Generally, a score of 0 means the participant is completely unable to perform the test, while a score of 4 means the participant can complete the action within the specified time or achieve the maximum required distance or range of motion for the task. Each test item has a clear description of the scoring criteria. The total score is 56, and a higher score indicates better balance ability.

    Time frame: From baseline to the end of treatment at 3 weeks

  2. Activities-Specific Balance Confidence scale

    This is a questionnaire that assesses the participant's level of self-confidence in maintaining balance in 16 situations commonly encountered in the community. Each of the 16 items is scored starting from 0, where 0 indicates no confidence, and scores increase in intervals of 10, with a maximum score of 100. A score of 100 represents complete confidence in maintaining balance.

    Time frame: From baseline to the end of treatment at 3 weeks

  3. Number of falls

    The number of falls experienced by the participant in the past year will first be recorded. The participant will then be provided with a fall diary to track the number of falls during the one-year follow-up period after the assessment. In this study, a fall is defined as when the individual unintentionally falls to the ground, floor, or another lower level position. Each month, a follow-up phone call will be made to ensure the participant is recording the fall count as required.

    Time frame: From baseline to the end of treatment at 3 weeks

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2025 (actual). Primary completion is estimated for Jul 2026, 16 months after the start.

Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 16 months is below that.

Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 9, 2025
First posted
Mar 27, 2025
StartActual
Mar 12, 2025
Primary completionEst.
Jul 31, 2026
CompletionEst.
Jul 31, 2026
Last update
Jun 10, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 10, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06898073
Lead sponsor
Fooyin University
Responsible party
Sponsor
First posted
Mar 27, 2025
Start date
Mar 12, 2025
Primary completion
Jul 31, 2026 (estimated)
Completion
Jul 31, 2026 (estimated)
Last update
Jun 10, 2025

Study contacts

I-Hsuan Chen
Contact
Y0894@fy.edu.tw
886-7-7811151#7043

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion